Title : Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.

Pub. Date : 2017 Aug

PMID : 28486761






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In LIM1215 cells, FTD induced extracellular signal-regulated kinase (ERK)/protein kinase B (AKT)/signal transducer and activator of transcription 3 (STAT3) phosphorylation and subsequent serine/threonine phosphorylation of EGFR, while it had no effects on EGFR tyrosine phosphorylation. Tyrosine AKT serine/threonine kinase 1 Homo sapiens
2 Panitumumab and the tyrosine kinase inhibitor erlotinib reduced the basal level of EGFR tyrosine phosphorylation and reversed FTD-induced ERK/AKT/STAT3 and EGFR serine/threonine phosphorylation. Tyrosine AKT serine/threonine kinase 1 Homo sapiens